Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery

Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.

Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare.

Dr. Shahin Fesharaki, Global Chief Scientific Officer, Lupin said, "This recognition underscores our dedication to advancing science and highlights Nanomi's pioneering efforts in drug delivery. We remain committed to innovation that enables the delivery of high-quality medicines that significantly improve patient outcomes."

Established in 2011, the CMO Leadership Awards are presented by Outsourced Pharma and Life Science Connect with research by Orientation Marketing and recognize top outsourcing partners, based on the feedback from sponsor companies who outsource manufacturing. This year is the first year that the CMO Leadership Award is juried.

Shares of Lupin Limited was last trading in BSE at Rs. 2115.70 as compared to the previous close of Rs. 2084.75. The total number of shares traded during the day was 8403 in over 1520 trades.

The stock hit an intraday high of Rs. 2124.00 and intraday low of 2085.00. The net turnover during the day was Rs. 17701873.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 Pharmaceuticals NanomiBV CMOAward LifeScienceLeadership DrugDelivery